Geftiget 250mg Tablet: Effective Relief for Your Health Needs

Uses of Geftiget 250mg Tablet

• Treatment of non-small cell lung cancer (NSCLC) in patients where the cancer has spread, who have certain types of abnormal epidermal growth factor (EGFR) genes, and patients who have not received any cancer treatment.

Therapeutic Effects

• Geftiget 250mg Tablet contains Gefitinib, an anilinoquinazoline derivative that interacts with a kinase inhibitor. This inhibits an abnormal protein called the epidermal growth factor receptor (EGFR), helping to slow or stop the growth of cancer cells and reduce the size of tumors in patients with NSCLC.

Dosage and Administration

• The usual recommended dosage is 250 mg tablet once daily.
• Take the tablet with or without food, as directed by your healthcare provider.
• Swallow the tablet whole with a glass of water.
• Take the Geftiget 250mg tablet at the same time every day.
• Do not crush, open, or dissolve the tablet.

Safety Advice

• Pregnancy: Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
• Breastfeeding: It is unsafe to breastfeed during the treatment with this tablet. Consult your doctor before breastfeeding.
• Lungs: Consult your doctor if you have any lung diseases before starting the treatment.
• Liver: Inform your physician if you have any liver problems before starting treatment.
• Alcohol: Avoid consuming alcohol as it may cause dizziness.
• Driving: It is unsafe to drive vehicles or operate heavy machinery after taking the tablet due to the risk of dizziness.

Side Effects

• Common side effects include diarrhea, nausea, vomiting, loss of appetite, weakness, red or sore mouth, increased liver enzymes, itchy or cracked skin, dry mouth, dry, red or itchy eyes, nail problems, hair loss, fever, blood in the urine, and burning sensation while urinating.

Precautions

• Store the tablet in the original package at room temperature (25°C).
• Keep it out of reach from children.
• If you have missed any dosing appointments, inform your doctor and schedule immediately.
• Avoid high-fiber foods and drink lots of fluids if you have severe diarrhea.
• Antacids should not be used two hours before or one hour after taking this tablet.

FAQs

• Q 1. What are the Geftiget 250mg tablet side effects? Diarrhea, nausea, vomiting, loss of appetite, weakness, red or sore mouth, increased liver enzymes, itchy or cracked skin, dry mouth, dry, red or itchy eyes, nail problems, hair loss, fever, nosebleed, blood in the urine, and burning sensation while urinating are the common Geftiget 250mg side effects.

• Q 2. Is Geftiget 250mg targeted therapy? Yes, Geftiget 250mg Tablet is a targeted drug therapy that helps to treat advanced non-small-cell lung cancer (NSCLC).

• Q 3. Who should not use Geftiget 250mg tablets? Geftiget 250mg is not indicated for children and adolescents under the age of 18. It should not be used in people who are allergic to this drug, as well as pregnant or breastfeeding women.

• Q 4. Is it safe for women of reproductive potential to use Geftiget 250mg tablets? Geftiget 250mg tablets are not recommended for use during pregnancy and breastfeeding. Tell your healthcare provider before starting this treatment if you are pregnant, think you might be pregnant, breastfeeding, or planning to have a baby.

• Q 5. What should I avoid while taking Geftiget 250mg tablets? It is advised to avoid taking an antacid or stomach acid-reducing medication within two hours before or one hour after taking a Geftiget 250mg tablet.

Fact Box

• Molecule name: Gefitinib
• Therapeutic class: Antineoplastics
• Pharmacological class: Tyrosine kinase inhibitors
• Indications: Non-small cell lung cancer

Теги: Geftiget, medication, tablets, 250mg, health, pharmacy, drug, treatment